Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom

VIHTA K. et al, (2022), Clinical Infectious Diseases

uantifying the Primary and Secondary Effects of Antimicrobial Resistance on Surgery Patients: Methods and Data Sources for Empirical Estimation in England

POUWELS K., (2022), Frontiers in Public Health

Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2)

Ward IL. et al, (2022), BMJ: British Medical Journal

SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection.

Wei J. et al, (2022), Nat Commun, 13

Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records.

Yoon CH. et al, (2022), J Antimicrob Chemother

Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study.

Ayoubkhani D. et al, (2022), BMJ, 377

Changes in the trajectory of Long Covid symptoms following COVID-19 vaccination: community-based cohort study

Ayoubkhani D. et al, (2022), BMJ: British Medical Journal

Author response.

Borek A. et al, (2022), Br J Gen Pract, 72

Risk of COVID-19 related deaths for SARS-CoV-2 Omicron (B.1.1.529) compared with Delta (B.1.617.2)

Ward I. et al, (2022)

Risk of Long Covid in people infected with SARS-CoV-2 after two doses of a COVID-19 vaccine: community-based, matched cohort study

Ayoubkhani D. et al, (2022)

Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines.

Wei J. et al, (2022), Nat Med

Mortality risks associated with empirical antibiotic activity in E. coli bacteraemia: an analysis of electronic health records

Yoon CH. et al, (2022)

Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom

Vihta K-D. et al, (2022)

SARS-CoV-2 anti-spike IgG antibody responses after second dose of ChAdOx1 or BNT162b2 and correlates of protection in the UK general population

Wei J. et al, (2022), Nature Medicine

Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.

Eyre DW. et al, (2022), N Engl J Med

Improving local prevalence estimates of SARS-CoV-2 infections using a causal debiasing framework.

Nicholson G. et al, (2022), Nat Microbiol, 7, 97 - 107

Modelling decay in effectiveness for evaluation of behaviour change interventions: a tutorial for public health economists.

Candio P. et al, (2021), Eur J Health Econ

Changes in the trajectory of Long Covid symptoms following COVID-19 vaccination: community-based cohort study

Ayoubkhani D. et al, (2021)

The challenge of limited vaccine supplies: impact of prior infection on anti-spike IgG antibody trajectories after a single COVID-19 vaccination

Wei J. et al, (2021)

Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom.

Walker AS. et al, (2021), N Engl J Med

Load More

1
2
3
4
5
6
7

Include forthcoming?